A 63-year-old female with stage IE diffuse large B-cell lymphoma developed reversible posterior leukoencephalopathy syndrome (RPLS) following CHOP chemotherapy, with typical clinical and radiological findings RPLS is a rare neurological syndrome characterised by visual disturbances, seizures, headaches and altered conscious level which has been associated with malignant hypertension, pre-eclampsia and some drugs, including ciclosponn. It has not been previously reported following CHOP chemotherapy Alternative treatment should be considered for patients who develop this rare complication
Introduction
Reversible posterior leukoencephalopathy syndrome (RPLS) is a rare neurological syndrome characterised by visual disturbance, seizures, headache and altered mental status, associated with white matter changes, particularly in the occipital lobes. It has been most commonly reported in patients with malignant hypertension and pre-eclampsia RPLS has also been associated with ciclosporin therapy following renal, liver, and allogeneic bone marrow transplantation [1] . The syndrome has not previously been reported following cyclophosphamide, doxorubicin, vincnstine and prednisolone (CHOP) chemotherapy. We report a case of RPLS following CHOP chemotherapy for diffuse large B-cell lymphoma (DLBCL).
Case study
A 63-year-old female presented with a right breast lump in 1999. Excisional biopsy confirmed DLBCL, and staging investigations including computerised tomography (CT) of chest, abdomen and pelvis, bone marrow biopsy and cerebrospinal fluid (CSF) examination revealed no other sites of disease There was a past history of mesenteric thrombosis 35 years previously post partum, and 2 superficial vein thromboses in the 2 years prior to presentation.
The first cycle of standard CHOP chemotherapy with prophylactic intrathecal methotrexate (12.5 mg) was administered. Six days later the patient developed a severe occipital headache of sudden onset associated with a left homonymous hemianopia, and presented to hospital.
General examination was normal. Neurological examination revealed a left homonymous hemianopia, but no other signs.
Magnetic resonance imaging (MRI) of the brain performed the following day showed subtle hypenntense changes in the periventncular white matter posteriorly on theT2 weighted scans with striking hyperintensity in both thalami (Figure 1 ). In view of the patient's previous thromboses, treatment dose tinzaparin was commenced, but magnetic resonance venography showed no evidence of venous occlusion. CSF microbiology and cytology were normal, but CSF protein was slightly elevated at 540 mg/1 (normal: 150-400 mg/1).
The visual symptoms and signs resolved over the next few days, though the blood pressure was moderately elevated Five days after admission she had a sudden episode of unconsciousness lasting one minute. No seizure was witnessed, and on regaining consciousness the patient was confused with an abbreviated mental test score (AMTS) of 2/10. General examination was normal apart from a blood pressure of 160/90. Neurological examination revealed hyper-reflexia throughout, but no other signs. CT brain imaging performed shortly afterwards showed no evidence of acute haemorrhage or infarction, though there was subtle low attenuation in the deep white matter of both occipital lobes in keeping with oedema.
The following day the visual symptoms returned with associated visual hallucinations as well as blurring of vision and frank left homonymous hemianopia.
An electroencephalogram showed right occipital and parietal slow waves with minor left sided abnormalities. Echocardiography, carotid doppler examination and a repeat lumbar puncture were all normal apart from a Repeat MRI scanning performed ten days following admission showed grossly abnormal high signal in the deep white matter of both occipital and parietal lobes, worse on the right than on the left, though the signal change in the thalami had resolved (Figure 2) .
A diagnosis of RPLS was made. Over the following week, the visual symptoms completely resolved, her mental status returned to normal, and the patient was discharged from hospital. Repeat MRI scanning three months after discharge showed almost complete resolution of the white matter changes.
Further chemotherapy was abandoned in favour of involved field radiotherapy to the right breast. Assessment of the patient's coagulation profile showed her to be a heterozygous carrier of factor V Leiden. The patient was commenced on aspirin.
Discussion
This patient's symptoms and radiological findings fit well with previous descriptions of RPLS [1] . RPLS has been most commonly reported in association with hypertensive crises where the pathological process is thought to be one of cerebral oedema and petechial haemorrhage that favours the posterior circulation [2, 3] . RPLS has also been reported after ciclosponn and tacrolimus (FK506) which may have a direct toxic effect on the cerebral vasculature [1] .
RPLS has been reported following cisplatin therapy for adenocarcinoma of the ovary [4] , but not to our knowledge following CHOP chemotherapy. A case of rapidly progressive fatal leukoencephalopathy has been reported following CHOP chemotherapy [5] . Interpretation of the latter is complicated by the use of additional high dose steroids in the treatment of the patient to compensate for her pre-existing panhypopituitarism. The present case is distinct from the latter in its reversibility and its close fit to the classical description of RPLSbyHincheyetal [l] .
Prophylactic intrathecal methotrexate was administered in this case Intrathecal methotrexate is associated with an acute, generalised encephalopathy [6] , and intrathecal methotrexate with cranial irradiation can cause a necrotising leukoencephalopathy leading to severe neurological impairment and death [7] . This combination treatment may also cause long term effects on neuropsychological function [8] . However, the reversible occipital white matter changes together with our patient's predominantly visual symptoms do not fit with previously reported manifestations of methotrexate neurotoxicity.
The cause of RPLS in this patient is unclear. One of the drugs in her CHOP regimen may have had a toxic effect on her cerebral vasculature. Vincristine has been associated with neurological side effects, most commonly peripheral neuropathy, but also encephalopathy [9] . The patient's encephalopathic presentation and slowly fluctuating clinical signs do not fit with multiple veno-occlusive events Despite the well known association between hypertension and RPLS it seems unlikely that the mild hypertension seen in our patient was a primary cause of her symptoms. RPLS is a rare complication of CHOP chemotherapy, but should be considered in patients who present with visual disturbances, altered conscious level, and deep white matter changes in a predominantly occipital distribution seen on MRI Alternative modalities of treatment should be considered in these patients.
